Journey Colab
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $12M
Investors
- 5
About Journey Colab
Based in California, US, and founded in 2020, Journey Colab Corp. operates as a psychedelic pharmaceutical startup company that was founded by its current CEO Jeeshan Chowdhury. The company develops a pipeline of psychedelic treatments used for the treatment of mental health-related problems of individuals and strengthens communities. will be able to fund its plan to accelerate the development of its psychedelic compounds. The company also plans to initiate its Phase 1 study of JOUR-001 for AUD in 2022.
Who invested in Journey Colab
5 investors across 1 round
See all investors in Journey Colab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 7, 2021
Amount
$12M
Investors
Questions about Journey Colab
Who invested in Journey Colab?
Journey Colab has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Journey Colab raised?
Journey Colab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Journey Colab last raise money?
Journey Colab's most recent round on record is a Series A, in Sep 2021.
What does Journey Colab do?
Based in California, US, and founded in 2020, Journey Colab Corp.
Where is Journey Colab headquartered?
Journey Colab is headquartered in San Francisco, US.
Which VCs invest in companies like Journey Colab?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Journey Colab's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Journey Colab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.